United States 119th Congress Status: In Committee Bipartisan · 4 R · 3 D cosponsors

S 3076 — Nitazene Control Act

Last action — Read twice and referred to the Committee on the Judiciary.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced October 30, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 7 sponsors

    1 primary, 6 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (4 R · 3 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

3 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill permanently schedules the class of 2-benzylbenzimidazole opioids known as nitazenes as Schedule I controlled substances under the Controlled Substances Act.

  • 21 U.S.C. 812(c)

    (f)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a 2-benzylbenzimidazole opioid, or which contains the salts, isomers, and salts of isomers of a 2-benzylbenzimidazole opioid.

    This addition permanently includes nitazenes and their derivatives as Schedule I controlled substances.

  • 21 U.S.C. 812(c)

    (f)(2) For purposes of paragraph (1), the term `2-benzylbenzimidazole opioid' includes the following: (A) A substance that is structurally related to 2-benzylbenzimidazole with the following modifications: (i) At the 1-position, substitution with an alkyl linker connected to a substituted amine group containing hydrogen, alkyl, alkenyl, or heteroaryl group, such as a morphilino, pyrrolidino, or piperidinyl groups, whether or not further substituted. (ii) At the 2-position-- (I) replacement of the alkyl portion of the benzyl group with a substituted or unsubstituted alkyl, alkoxy, carbamates group, nitrogen, sulfur, or oxygen atom; or (II) replacement of the phenyl portion of the benzyl group with an aryl or heteroaryl group. (iii) Substitution on the phenyl portion of the benzimidazole ring with a hydrogen atom, halogen, nitro, cyano, substituted or unsubstituted amide, amine, alkyl, alkoxy, aryl, or heteroaryl group. (iv) At the 6-position, substitution with hydrogen, nitro, trifluoromethyl, methoxy, trifluoromethoxy, cyano, and halogen groups. (B) A substance that exhibits agonist activity at the mu-opioid receptor. (C) Etonitazene, clonitazene, metonitazene, isotonitazene, protonitazene, butonitazene, etodesnitazene, flunitazene, N-pyrrolidino etonitazene, N-desethyl isotonitazene, and N-piperidinyl etonitazene.

    This definition broadens the classification to include various related compounds and establishes criteria for identifying new analogs.

  • 21 U.S.C. 811(h)

    Any substance included in the amendment made by subsection (a) that was temporarily scheduled under section 201(h) of the Controlled Substances Act (21 U.S.C. 811(h)) shall be deemed permanently scheduled and subject to the requirements of schedule I of section 202(c) of that Act (21 U.S.C. 812(c)) as of the date of enactment of this Act.

    This change removes the temporary status of substances listed in the new classification, making them permanently scheduled.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on the Judiciary.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 6 co-sponsors · 540 not signed on

Sponsors (1)

Co-sponsors (6)

Not signed on (540)

540 members have not signed on to this bill.

Show all 540 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 3076?
S 3076 is sponsored by McCormick, David (Republican), Gallego, Ruben (Democratic), Ricketts, Pete (Republican), Shaheen, Jeanne (Democratic), Schmitt, Eric (Republican), Slotkin, Elissa (Democratic), and Moody, Ashley (Republican).
What is the current status of S 3076?
This bill is in committee in the Senate. Introduced October 30, 2025. It must pass committee before a floor vote.
Where can I track S 3076?
Track S 3076 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 3076

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 3076

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →